ADAGE Capital Partners Gp, LLC, 10% Owner at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 380,452 shares at $68.13 ($27.5M) on 2017-05-24, disclosed to the SEC on 2017-05-26.
Open-market sale of $27.5M PBYI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.13 | 50,000 | $3.4M | 12.4% |
| 2 | $70.31 | 53,600 | $3.8M | 13.7% |
| 3 | $72.22 | 52,300 | $3.8M | 13.8% |
| 4 | $73.29 | 175,687 | $12.9M | 46.9% |
| 5 | $74.49 | 48,865 | $3.6M | 13.3% |
| Total | $72.20 avg | 380,452 |
| $27.5M |
| 100% |
| Filing → |
| GCMG | SELL | 2021-07-13 | $8.6M | — | Filing → |
| GCMG | SELL | 2021-07-13 | $1.5M | — | Filing → |
| GCMG | BUY | 2021-07-13 | $602K | — | Filing → |